Endoformin VG 2mg/500mg/0.2mg Tablet ER
Marketer
Precia Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Endoformin VG 2mg/500mg/0.2mg Tablet ER
Diabex Trio (2mg/500mg/0.2mg Extended-Release Tablets) is an antidiabetic medication, a combination therapy for adult type 2 diabetes. It helps regulate blood glucose. Diabex Trio should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn its symptoms (sweating, dizziness, headache, trembling) and treatment. Regular meals and readily available glucose (e.g., sugary snacks, juice) are essential. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Diabex Trio is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your doctor of any heart history before starting treatment; it may be unsuitable. Pregnant or breastfeeding individuals require physician consultation. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to check blood cell counts and liver function.
Primary Ingredients of Endoformin VG 2mg/500mg/0.2mg Tablet ER
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Endoformin VG 2mg/500mg/0.2mg Tablet ER
Managing type 2 diabetes
Major Benefits of Endoformin VG 2mg/500mg/0.2mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Endoformin VG 2mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.
Common Side effects of Endoformin VG 2mg/500mg/0.2mg Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Endoformin VG 2mg/500mg/0.2mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Endoformin VG 2mg/500mg/0.2mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
How Endoformin VG 2mg/500mg/0.2mg Tablet ER works:
Extended-release Endoformin VG tablets (2mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Endoformin VG 2mg/500mg/0.2mg Extended-Release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Endoformin VG tablet (2mg/500mg/0.2mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Endoformin VG tablets (2mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk with consequent risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Endoformin VG 2mg/500mg/0.2mg Extended-Release Tablets are likely unsafe for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Endoformin VG 2mg/500mg/0.2mg Extended-Release Tablets cautiously. Dosage modification of Endoformin VG 2mg/500mg/0.2mg Extended-Release Tablets may be necessary. Physician consultation is advised. Initiation with a reduced dose is typical for those with mild to moderate hepatic dysfunction; its use is contraindicated in patients with severe liver disease.
What if you forget to take Endoformin VG 2mg/500mg/0.2mg Tablet ER :
Should you forget a dose of Endoformin VG 2mg/500mg/0.2mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Endoformin VG 2mg/500mg/0.2mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently